article thumbnail

Antidepressant Use Linked to Sexual Dysfunction, Why Aren’t Prescribers Discussing It?

Mad in America

Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine. Maelys Touya was an employee of Lundbeck LLC, and Lambros Chrones was an employee of Takeda Pharmaceuticals U.S.A., The study was authored by Judith J. Additionally, Anita H.

article thumbnail

The Iatrogenic Gaze: How We Forgot That Psychiatry Could Be Harmful

Mad in America

Doctors became hypnotized by the appearance of “science”, even if the literature they consulted was essentially pharmaceutical advertising. Such optimism would be disappointed by dwindling pharmaceutical progress in the later half of the century. When medications did cause harm, the doctors were completely blind to it.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

‘We Hold You Sacred’: Fighting the Opioid Crisis in the Cherokee Nation

Mad in America

From The Guardian : “In 2017, the Cherokee Nation became the first tribe to file a lawsuit against opioid manufacturers and distributors for promoting the flow of prescription opioids into its community.

article thumbnail

The Madness Industrial Complex

Psychiatric News

The toxic pills distributed en masse by the pharmaceutical behemoths have led to more deaths in the U.S. While psychiatrists are culpable as the pushers of these brain-altering nightmare pills, the industry that manufactures and promotes them (AKA Big Pharma) deserves their own Nuremberg. than the Vietnam War. See article HERE

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Four)

Mad in America

There was no placebo group, and all patients started on citalopram, manufactured by Lundbeck, which was motivated by horrendously erroneous claims of citalopram’s “absence of discontinuation symptoms” and its “safety” in elderly patients. Nothing in Insel’s narrative would harm psychiatry’s guild interests or pharmaceutical interests.

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Six)

Mad in America

Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst.

article thumbnail

The American Journal of Psychiatry’s Answer to MIA: A Silence that Speaks Volumes

Mad in America

However, in the summer of 1990, the Prozac story started to come undone, and it was then that the pharmaceutical industry, in concert with its thought leaders from academic psychiatry, plotted the strategy that has successfully cowed the mainstream media ever since.